STEP 2 39 enrolled individuals with type 2 diabetes [glycated haemoglobin (HbA1c) 7.0%10.0%], and randomized them to onceweekly subcutaneous semaglutide 2.4 mg, semaglutide 1.0 mg (the approved dose in type 2 diabetes) or placebo for 68 weeks
Understanding the mechanisms behind weight regain empowers you to build sustainable habits alongside medical therapy
Whether youre struggling with obesity or looking to manage weight-related health issues, our medically supervised approach ensures a safe and effective journey
These side effects were observed during dose escalation and subsided with lowering the dosage of retatrutide
Crossindustry collaboration on cost containment: Employers, plans, health systems, and policy stakeholders are collaborating more intentionally around best practices for cost predictability and management
Customized Treatment Plan: Based on your needs, we develop a personalized program that includes GLP-1 medications, nutritional guidance, and lifestyle coaching